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CHAPTER I 
INTRODUCTION
Psychopharmacological studies traditionally have 
been somewhat atheoretical in character, being motivated by 
applied, usually clinical interests. These studies, often 
involving an arbitrary drug, examined a subject's performance 
on some task in order to determine whether the drug had any 
effect on behavior associated with the task. Such studies 
have yielded a great deal of information regarding specific 
effects of drugs on specific behaviors, and occasionally, 
they have led to the discovery of neural systems which seem 
to be mediated by one class of compounds; i.e. a cholinergic 
drinking system and a noradrenergic eating system within the 
limbic-hypothalamic areas of the rat brain (Grossman, i960).
Currently there is a trend to use techniques and 
strategies suited to obtaining information about basic 
biochemical mechanisms in an organism which is relatively 
unperturbed by the administration of a large dose of a drug.
1
2In line with this approach, the present investigation 
attempted to obtain information on the relative importance 
of adrenergic and serotonergic systems for self-stimulation 
(SS) behavior in rats by examining release of the monoamines 
during either rewarding or non-rewarding electrical stimu­
lation of the brain (ESB) or during auditory and visual 
stimulation (AVS).
In 1954 Delgado, Roberts, and Miller (195^) reported 
that electrical stimulation of some thalamic and hippocampal 
sites provided aversive motivation for several forms of 
learning. In the same year. Olds and Milner (1954) found 
that electrical stimulation of parts of the hypothalamus 
and septal regions had rewarding or reinforcing effects on 
behavior, since rats would press a lever at very high rates 
to obtain such stimulation. Subsequent work has demonstrated 
similar effects in a number of different species of animals 
including subjective reports of pleasure and pain in humans 
after electrical stimulation of subcortical regions (Heath 
& Mickle, i960). These first reports fostered a vast number 
of research projects concerned with the phenomena of SS. 
Factors investigated have included brain loci from which 
either positive or negative effects can be elicited (Olds, 
Travis, & Schwing, 1960; Olds, 1962; Roberts, 1958; Bower & 
Miller, 1958; and Posohel, 1966); electrical parameters 
(Stein, 1962; Keesey, 1962; Keesey, 1964; Plutchik, McFarland, 
& Robinson, I966); manipulation of certain basic drives such
3as hunger, thirst, and sex (Olds, 1962; Valenstein, 1966); 
lesion effects (Lorens, 1966); and the effects of various 
drugs and chemicals.
The results of these investigations now constitute an 
important body of evidence related to the theoretical issues 
of reinforcement and motivation, with at least two review 
papers making major contributions to the field, one by Olds 
in 1962 and another by Glickman and Schiff in I967.
Biological Theories of Reinforcement
While many traditional theories postulate drive 
reduction (Hull, 1943) or reduction of drive stimuli 
(Miller & Bollard, 1941) as the essential requirement for 
reinforcement, a somewhat different view has been taken by 
Glickman and Schiff (I967). In the tradition of response 
theories such as Sheffield's (1948) they place the emphasis 
on species-specific responses. Relying heavily on contri­
butions made by Valenstein (I966), they conclude that 
reinforcement consists of activation of neuronal systems 
within the brainstem mediating the expression of the 
species-specific responses. They view reinforcers as those 
stimuli which are capable of facilitating the activity of 
these neuronal systems. For these authors, approach 
behavior is positively reinforcing and withdrawal behavior 
is negatively reinforcing. Various other theories of 
reinforcement have emphasized such factors as incentive and 
activation.
4At the neurochemical level, what might be the 
mediator of such neural systems? A number of studies to 
be enumerated further in this dissertation strongly suggest 
that noradrenergic systems are specifically involved in SS 
behavior. It seems likely that norepinephrine (NE) is the 
responsible agent for initiating and sustaining the approach 
and consummatory behavior which results in reinforcement. 
Stein (1970) has evidence that NE acts on the amygdala in 
rats as an inhibitory transmitter. This, he believes, 
results in disinhibition of approach-consummatory behavior 
mediated by the forebrain.
Drug and Biochemical Effects on Self-Stimulation
The mass of experiments concerned with drug effects 
on SS has produced a tentative hypothesis that adrenergic 
and/or anticholinergic compounds tend to potentiate SS 
while cholinergic and/or antladrenerglc compounds tend to 
decrease SS, Moreover, It appears that serotonin Is also 
Involved in the neural systems responsible for SS. Findings 
for this monoamine have been somewhat less consistent, 
however, possibly because mechanisms of drug action and 
antagonism are less well understood for serotonergic systems.
Neurochemistry of Acetylcholine,
Norepinephrine, and Serotonin 
In order to sort out the effects on neural mechanisms 
produced by various pharmacological agents it is necessary
5to examine some of the neurochemlstry of the biogenic 
compoiinds before continuing with a review of their effects 
on SS.
The three neurohumors to be considered, acetylcholine, 
norepinephrine, and serotonin, all occur naturally within 
the central nervous system, specifically in the region of the 
lateral hypothalamus, amygdala, and the median forebrain 
bundle (MFB) (Eiduson, Geller, Yuwiler, & Eiduson, 1964; 
Hillarp, Fuxe, & Dahlstrom, 1966), Furthermore, the enzyme 
systems responsible for the biosynthesis and metabolism 
of these substances are found in these same regions.
Briefly, for each neurohumor, the normal pathway of biosyn­
thesis and degradation will be considered as will the 
compounds which either simulate or potentiate its primary 
effects and the compounds which antagonize or deplete the 
substance.
Acetylcholine. The biosynthesis of acetylcholine 
requires acetyl CoA and choline which combine to form 
acetylcholine in the presence of the enzyme choline acet- 
ylase. (see figure 1) It is degraded in the presence of 
cholinesterase into choline and acetate.
Acetylcholine is the neurotransmitter for the 
parasympathetic division of the autonomic nervous system. 
Released into the synaptic space upon the arrival of a neural 
impulse, it acts on the postsynaptic membrane resulting in 
the initiation of another impulse in the postsynaptic
Figure 1 - The biosynthesis and degradation of 
Acetylcholine.
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8neuron. Its removal from the synaptic space is accom­
plished by degradation by the enzyme cholinesterase.
Cholinergic postsynaptic receptors appear to be of 
two types; muscarinic and nicotinic. The cholinomimetic 
effects of drugs on autonomic effector cells are called 
muscarinic while a stimulation effect followed by a 
blockade of autonomic ganglia and skeletal muscle are 
called nicotinic.
Carbachol is a synthetic compound which mimics the 
effects of acetylcholine, whereas atropine is a muscarinic 
cholinergic antagonist which is in competition with acetyl­
choline at the postsynaptic site. Physostigmine (eserine) 
an anticholinesterase, blocks the degradation of acetyl­
choline.
Norepinephrine. The catecholamine, norepinephrine 
(NE), is synthesized from the amino acid phenylalanine. 
Phenylalanine is hydrorylated into tyrosine which is further 
hydrozylated into dihydrozyphenylalanine (DOPA). DOPA is 
then decarboxylated into dopamine which is further hydrox- 
ylated into NE. One degradation pathway for NE involves 
o-methylatlon in the presence of catechol o-methyl trans­
ferase resulting in normetanephrine. (see figure 2) This 
compound is further metabolized and excreted as a glycol. 
This degradation pathway is believed to be the primary one 
for extracellular NE. Another degradation pathway for NE 
occurs inside the cell in the presence of monoamine oxidase
Figure 2 - The biosynthesis and degradation, of 
norepinephrine.
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(MAO), and results in deaminated "biproducts.
With the arrival of a neural action potential, NE is 
released into the synapse to act upon postsynaptic sites.
Then it is removed either by reabsorption into the presynaptie 
cell, the primary method (and thus subject to metabolism by 
intracellular MAO), or by extracellular metabolism with 
catechol o-methyl transferase.
Alpha-methy1-meta-tyrosine is an inhibitor of 
decarboxylase and thus lowers the concentration of NE, 
dopamine, and serotonin.
Reserpine depletes NE, dopamine, and serotonin 
(Holzbauer & Voft, 1956; Carlson, Lindquist, Magnusson, & 
Waldeck, 1958) by impairing the vesicular binding sites for 
the monoamines, releasing them into the cell and preventing 
their reabsorption.
Amphetamine has adrenergic potentiating properties 
acting to release NE and possibly also as a MAO inhibitor 
(Goodman & Gilman, I965), Dibenzaline is an adrenergic 
blocking compound acting at the postsynaptic receptor sites.
8ix-hydroxydopamine results in a long lasting depletion of 
NE due to neuron end-terminal damage.
Serotonin. The indoleamine serotonin or 5“bydroxy- 
tryptamine (5-HT) is synthesized from the amino acid trypto­
phan (see figure 3)» first by hydroxylation to 5“hydroxy- 
tryptophan (5-HTP) then by decarboxylation to 5-HT. Its 
degradation is accomplished either by monoamine oxidase
12
Figure 3 - The biosynthesis and degradation of 
serotonin.
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(the major pathway) producing 5~hydroxy-indoleacetic acid 
(5-HIAA) or by catechol o-methyl transferase. Both the syn­
thesizing and degradation enzymes in the NE and 5-HT path­
ways are quite similar (i.e. DOPA and 5-HTP decarboxylase) 
and in mstny cases are found to be identical.
Para-chlorophenylalanine (PCPA) is a drug which 
blocks the synthesis of 5-HT by inhibiting the rate limiting 
step of the 5-bydroxylation of tryptophan (Koe & Weissman, 
1966), thus lowering the concentration of 5-HT in body and 
brain. LSD is structurally similar to 5-HT and in many 
cases blocks its effects, and bromolysergic acid diethylamide 
(Brom-LSD) is in some instances also a 5-HT antagonist. 
Para-chloroamnhetamine is a compound which releases serotonin 
(Miller, Cox, Snodgrass, & Maicke, 1970).
Drugs acting on both NE and 5-HT. In general MAO 
inhibitors potentiate the effects of both NE and 5-HT by 
inhibiting the metabolism of both substances. Iproniazid 
and pargyline hydrochloride are exemplary MAO inhibitors. 
However, it has been reported that phenylisopropylhydrazine 
(JB-516), an MAO inhibitor in dogs, can cause an elevation 
of 5-HT levels with no increase in catecholamine levels 
(Mailing, Highman, & Spector, 1962; Spector, Shore, & Brodie,
i960).
Reserpine, as previously mentioned, releases and 
impairs the bonding sites for both the catecholamines and 
serotonin.
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Imipramine and amitryptyline alter the permeability 
of the cell membrane to catechol and indole amines (Goodman 
& Gilman, 19&5) potentiating the effects of "free" inter­
cellular NE and 5-HT.
Upon intravenous administration of aluha-methyl- 
meta-tyrosine or aluha-methyl dopa to guinea pigs, rats, 
pigeons, and mice the decarboxylase enzyme is inhibited and 
levels of NE, 5-HT, and dopamine are reduced (Sourkes,
Murphy, Chavez, & Zielinska, 19&1; Hess, Connamacher, Ozaki,
& Udenfriend, I96I; Porter, Totaro, & Leiby, I96I; Sourkes, 
1954; H i n ^ m  & Aprison, 1963). After administration of these 
decarboxylase inhibitors the three humors return to their 
preadministration level at different times; dopamine at six 
to eight hours, and 5-HT at three and one half to twenty 
hours, whereas NE remains low at twenty hours and does not 
return to normal levels before seventy-two to ninety-six 
hours.
Studies Relating to Self-Stimulation
Four general techniques have been employed to 
investigate drug or biochemical effects on 88. In the first, 
the drug is introduced systemically after which alterations 
in response rates or electrical current thresholds for 86 
are measured. The second technique, a procedure which has 
met with many difficulties, is self-injection of chemicals 
directly into the brain. The main difficulty with this 
method is that the amount injected at one time is usually
16
so large or has such profound behavioral effects as to make 
it difficult to use 88 response rate as a measure of its 
action. Often, some of the chemical remains in the cannula 
for a long period of time, making it unnecessary for the 
animal to respond during this time. The third method is to 
inject chemicals into the site of the stimulating electrode 
and again measure alterations in response rate or differences 
in current thresholds. The fourth method is to allow the 
animal to 58 and measure various substances in his brain.
A modification of this later method was the approach used in 
this research.
Studies reviewed in the following sections involve 
drugs which are known to affect both 88 and either the 
cholinergic, adrenergic, or serotonergic systems. All studies 
used rats as subjects except as indicated otherwise.
88 cholinergic mechanisms ; pharmacological studies. 
Some of the most striking effects on 88 behavior have been 
found with chlorpromazlne (Olds, Killam, & Bach-Y-Eita, 1956; 
Miller, 1957; Olds, Killam, & Eiduson, 1957; Olds, 1957; Olds, 
1958; Olds & Olds, 1958; Olds, 1959%; Olds & Travis, 196O; 
Stein & Bay, I96O; Stein, 1961, Stein & Seifter, I96I; Stein, 
1962; Olds, 1962; Olds & Olds, 1964). This drug, a major 
tranquilizer in man, reliably increased the threshold for 88 
and lowered the animal's rate of responding. In general, 
other phenothiazines have the same effect on responding. It 
is interesting to note that five phenothiazines which seem
17
to have varying degrees of effectiveness on psychotic 
symptoms bear the same relationship in the same order to 
88 (8tein, I96I; Olds, 1962). Promethazine increased 88, 
promazine had no effect, chlorpromazine reduced, and 
prochlorperazine and trifluoroperazine were extremely 
powerful in eliminating responding. The last two drugs were 
also found to be especially effective in treating psychotics. 
A similar ranking was found for these drugs in the 
modulation of cholinergic effects. Although Bradley (1965) 
does not explain the exact nature of the antagonism, he 
reports that promethazine has a strong antagonism to the 
effects of acetylcholine. Promazine has a somewhat less 
antagonistic effect along with chlorpromazine. And, tri­
fluoroperazine has no antagonism to acetylcholine. Further, 
these drugs are ordered in the same way for their relative 
pharmacological antagonism to serotonin. One notes that those 
phenothiazines which have largest antagonistic effects on 
acetylcholine and serotonin have the least effects and may 
even have a potentiating effect on 88.
Consistent with the hypothesis that cholinergic 
stimulating drugs decrease 88, research by Olds and Domino
(1969) demonstrated that muscarinic cholinergic drugs 
depressed 88 whereas nicotinic cholinergic drugs had a more 
complex depressant and stimulant effect. Brophy and Todd
(1970) found that when drugs were deposited at the site of 88 
electrodes, carbachol markedly and acetylcholine moderately
18
reduced 88 rates. Moreover, this effect could be atten­
uated by atropine.
88 adrenergic mechanisms ; nharmacological studies. 
Amphetamine has also been widely investigated with the 
finding that it markedly decreased the threshold for 88 and 
increased response rates (Miller, 1957» Olds, 1959%; Stein 
& Ray, I96O; Stein, I96I; Stein & Seifter, I96I; Stein, 1962; 
Olds & Olds, 1964; Stein, 1964). Miller (1957) reported 
an interesting relationship in which methamphetamine acts to 
increase the time to turn the stimulation off while chlor­
promazine acts to increase the time to turn it on. When 
methamphetamine was administered subsequent to imipramine 
hydrochloride (a potentiator of "free" intracellular and 
extracellular ME and 5-HT), the potentiating effects of 
methamphetamine on S3 parameters were augmented (Stein, I96I; 
Stein, 1962). Stein (1962) administered chlorpromazine, 
which decreases 88, and found that its effect was antagonized 
by methamphetamine. This was true regardless of which drug 
was administered first.
Phenethylamine, the basic adrenergic structural 
compound, increased 88 (Stein, 1964). Also, if phenylalanine 
was administered after iproniazid (an MAO inhibitor) the 
potentiating effect on response rate was especially strong.
Reserpine, releasing both the catecholamines and 5-HT, 
produced a biphasic effect in that it reduced response rates 
within forty-five minutes after administration but subse­
19
quently caused a persistent elevation in responding lasting 
for as long as twelve days (Stein, 1962). When reserpine 
was followed by amphetamine, its initial inhibitory effect 
on SS was reversed (Stein, I962). The administration of 
atropine followed by amphetamine also increased responding, 
but not as much as the administration of imipramine followed 
by amphetamine. Stein reported that amitriptyline (also a 
potentiator of intracellular and extracellular NE and 5-HT) 
enhanced the effect of amphetamine on SS.
Six-hydroxydopamine, which functionally destroys 
adrenergic end terminals, produced a progressive decrease in 
SS behavior over time (Stein, 1971)•
These studies just cited indicate that those 
compounds which in some manner potentiate the effects of NE, 
augment SS behavior while those compounds which suppress 
the effects of NE, decrease SS behavior.
Although for reasons mentioned earlier, the self- 
injection studies must be evaluated critically, one substance 
which caused substantial self-injection responding was 
iproniazid. This MAO inhibitor would be expected to increase 
the concentration of NE. In addition, NE seemed to cause 
some self-injection behavior, although this finding is 
somewhat uncertain (Olds, 1958; Olds, 1959a).
Paradoxically Brophy and Todd (1970), depositing 
drugs at the site of SS found a decrease in responding after 
both NE and dibenzyline (an adrenergic blocking agent).
20
However, histological examination indicated the drugs had 
caused lesions at the sites of the electrodes, making any 
conclus ions ques tionable.
SS adrenergic mechanisms ; biochemical analysis. A 
new approach to the investigation of adrenergic mechanisms 
in SS was reported by Bliss, Wilson, and Zwanziger (1966). 
Stimulating electrodes were implanted in the posterior 
hypothalamus and the medial lemniscus of rats. Stimulation 
sites were evaluated for their tendency to induce SS or 
escape behavior. Animals that stimulated themselves 
spontaneously more than 2000 times per hour were labeled 
self-stimulators, whereas those who responded less them five 
times per hour and showed startle or withdrawal reactions 
were called aversive animals. Biochemical analysis revealed 
drops of twenty per cent in NE levels in the hypothalamus 
as well as in the rest of the brain in both SS and aversive 
animals. Animals in the Bliss, Wilson, and Zwanziger study 
were yoked so that one rat was allowed to self-stimulate, 
receiving "active" stimulation, while his partner received 
"passive" stimulation. Passively stimulated animals showed 
a small reduction in NE just bordering on statistical 
significance (p<0.10). It was also determined that brain 
levels of NE did not differ between unimplanted animals and 
animals who were implanted but received no stimulation.
Bats, which had not proven to be self-stimulators, 
but which had electrodes implanted in the hypothalamus, were
21
then stimulated at a rate of 3000 per hour. These animals 
also showed a decrease in NE as well as emotional responses 
to the stimulation comparable to the SS group.
Finally, animals were implanted with electrodes 
located slightly to one side of the hypothalamic S3 sites. 
Automatic stimulation of these animals produced no or few 
emotional responses, and no decrease in NE levels in the 
brain. The authors suggested that the decrease in NE levels 
found in both SS and aversive animals reflects the depletion 
of NE occurring with the normal release of the neurohumor 
during synaptic transmission. The failure to differentiate 
self-stimulators from aversive animals on the basis of NE 
levels leads one to question whether NE itself is specific to 
the affective component of intracranial reinforcement. A 
major difficulty with this study, however, was that placement 
of the electrodes was not confirmed. Thus, the meaning of 
"in the hypothalamus" or "just outside" is not clear.
An ingenious study by Stein and Wise (1969) helps 
clarify the results of the Bliss, Wilson, and Zwanziger 
(1966) investigation. Since the research reported in this 
dissertation employed methods similar to those used by 
Stein and Wise, their study will be examined in detail.
These investigators implanted stimulating electrodes In the 
MFB of rats. In addition, a needle for injection of 
radioisotopes was Inserted into the lateral ventricle, and 
a push-pull cannula implanted into either the lateral
22
hypothalamus or the amygdala. Rats were taught to SS and 
evaluated for their SS "'erformance during a one hour test. 
Animals displaying rates of 1000 responses per hour or more 
were classified as being in a rewarding group. Others were 
classified in the non-rewarding group,
H3norepinephrine and C^^norepinephrine were Injected 
into the lateral ventricle of each animal and forty-five 
minutes later the animal was given electrical stimulation 
in the MFB delivered at a fixed rate of one train of 100 cps 
pulses per second, Locke-Ringer’s solution was perfused into 
the push-pull cannula and samples were taken every five 
minutes. The samples were assayed for NE, its deaminated 
metabolites, and normetanephrine. Stimulation in the 
rewarding group caused a marked increase in the radioactivity 
of the perfusates in both the hypothalamus and amygdala, the 
primary component being o-methylated derivatives of NE. 
Non-rewarding stimulation did not cause an increase in radio­
activity and in some cases, caused an inhibition of release. 
They further found that amphetamine injected i.£. caused 
release of NE from amygdaloid sites but not from hypothalamic 
sites.
On the basis of the release of NE from the hypothala­
mus and the amygdala during rewarding ESB the authors 
concluded that NE is released in central synapses at the 
terminal sites of the MFB in the hypothalamus and is respon­
sible in part for the positive reinforcement of behavior.
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The Stein and Wise study suggests that the rewarding 
effect of SS in rats is mediated by release and turnover of 
NE. However, conclusions about the specificity of this rela­
tionship depend on answers to the following questions; (1) Is 
the release of NE specific to rewarding ESB? Stein and Wise 
utilized only ESB, but it is possible that the release is not 
specific to rewarding ESB but might occur with the presenta­
tion of any stimulus, (2) Is the release of biogenic sub­
stances limited to NE or are other biogenic amines which are 
present in that area of the brain (i.e., 5-HT) also released? 
If so, they may be equally important for reinforcement pro­
cesses. (3) Does ESB, and/or other peripheral stimuli, pro­
mote the "release" of other compounds (e.g., urea) which are 
relatively inert with respect to normal nervous functioning? 
If the latter were found to be true, Stein's concept of the 
specificity of NE in the mechanisms of reinforcement would be 
gravely challenged.
SS serotonergic mechanisms ; uharmacological studies. 
The combined effects of LSD and 5-HT have been examined by 
Olds, Killam & Eiduson (1957); Olds (1959b) and Olds & Olds 
(1964), There were electrode sites in which LSD reduced re­
sponding but this effect could be antagonized by pre-admini­
stration of 5-HT one hour earlier. At these same sites Brom- 
LSD, a 5-HT antagonist, had no effect. These sites included 
the septal region, the preoptic region, and the extreme pos­
terior-ventral hypothalamus. With other electrode placements.
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however, both LSD and Brom-LSD reduced responding and this 
effect was not blocked by prior administration of 5-HT.
Stark, Boyd, and Fuller (1964), using dogs, studied 
the effects of three drugs ; (1) aluha-methvl dopa, three
and one half, eight, and twenty-four hours after administra­
tion; (2) JB-516 (a MAO inhibitor relatively specific to se­
rotonergic mechanisms), twenty-four hours to five days after 
administration; and (3) Brom-LSD, ten minutes after adminis­
tration.
Aluha-methvl dopa, which depletes 5-HT and NE, caused 
complete inhibition of SS at three and one half hours. Per­
formance returned almost to control levels at eight hours and 
showed complete recovery at twenty hours. Brain levels of 
5-HT were fifty-three per cent of control levels at three and 
one half hours, seventy per cent at eight hours, and eighty- 
three per cent at twenty hours. However, at twenty hours the 
level of NE in the brain was still only sixty-three per cent 
of control levels. Thus, inhibition of responding was asso­
ciated with depletion of both NE and 5-HT, but response re­
covery followed the recovery of 5-HT to control levels more 
closely than that of NE.
Forty-eight hours after JB-516 was administered, the 
electrical threshold for SS was lowered, and response rates 
(with fifty to one hundred microamps current Intensity) were 
increased in two of three animals. Rates with 125 microamps 
were about at pre-drug level and rates with 150 microamps
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were lower than control levels. In non-electrode dogs, brain 
serotonin levels forty-eight hours after administration of 
the drug were 15^ per cent of control.
With Brom-LSD, high doses tended to inhibit SS, while 
low doses were found to lower the threshold of SS in the same 
two of three dogs. (The third animal*s electrode was in a 
slightly different anatomical location.) Stark, Boyd, and 
Puller suggested that 5-HT may be responsible for the rein­
forcing effect of SS in that inhibition of responding with 
aluha-methyl dopa followed the curve of 5-HT depletion, while 
responding recovered before NE levels began to return to nor­
mal levels. The investigators failed to stress, however, 
that during the period of response inhibition, both NE and 
5-HT concentrations were lowered. Therefore, NE cannot be 
ruled out as a mediator of SS. Their study does suggest that 
both NE and 5-HT may mediate the neural mechanisms of rein­
forcement,
Poschel and Ninteman (1968) found that SS thresholds 
were lowered after administering the M O  inhibitor, pargyline 
hydrochloride followed by 5-HTP. The difference in results 
on SS threshold levels of administering a M O  inhibitor and 
raising brain levels of 5-HT between the Poschel and Ninteman 
(1968) and Stark, Boyd, and Fuller (1964) studies may be ex­
plained by the use of different current levels. The Poschel 
and Ninteman study used seventeen and one half and twenty- 
five microamps and the Stark, Boyd, and Fuller study used
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fifty to one htindred-fifty microamps.
Paradoxically, further research by Poschel and Ninte­
man (1971) employed PCPA, which inhibits 5-HT synthesis, and 
found an excitatory effect on SS behavior from three to seven 
days after administration. In addition, the serotonin re­
leasing compound uara-chloroamuhetamine produced an inhibitory 
effect on SS, As a result of their last studies, these re­
searchers postulated a theory that placed emphasis on both NE 
and 5“HT mechanisms for regulating reward thresholds, NE low­
ers thresholds for reinforcement and 5“HT raises thresholds. 
One may note from the studies on 5-HT mechanisms and 
SS that the results are anything but consistent and much fur­
ther research will have to be done in order to clarify the 
previously cited literature.
General Considerations for the Proposed Research
The psychopharmacological research reviewed above led 
to the hypothesis that an adrenergic mechanism is importantly 
involved in the maintenance and enhancement of SS behaviors. 
Moreover, it appears that there is a strong likelihood that 
serotonergic mechanisms also may play a part in SS behavior, 
although its precise role is more obscure. Thus, it is pro­
posed that both NE and 5-HT are necessary for the phenomenon 
of SS, perhaps each in a slightly different manner from the 
other.
Although the Stein and Mise (I969) study found a re­
lease of NE during rewarding ESB and no release or a decrease
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in release of NE during non-rewarding ESB, the Bliss, Wilson, 
and Zwanziger (1966) study found a decrease in brain levels 
of ME in both stimulators and non-stimulators. The decrease 
in ME found in the stimulators could be due to depletion pro­
duced by the release and rapid metabolism of the substance, 
whereas the decrease in the non-stimulators could be the re­
sult of an inhibition of the synthesis of ME. Studies cited 
by Page (1968) showed that the manufacture of neurohumors is 
dependent on neural impulses in an intact nervous system. Had 
Bliss and his co-workers measured ME metabolites in the brain 
as Stein and Wise did, this issue might have been settled.
The Stark, Boyd, and Fuller (1964) depletion data 
suggested that 5-HT was more closely associated with SS be­
havior than NE. Nevertheless, at the time inhibition of SS 
behavior occurred both NE and 5-HT were depleted. Further­
more, the increase in 5-HT induced by an MAO inhibitor made 
the animals much more sensitive to the effects of electrical 
stimulation. Their threshold for responding was decreased 
and their response rate increased at low current levels. At 
higher levels of current, however, which presumably produced 
more excitement, the increase in 5-HT did not change or, in 
fact, decreased rates of responding. Thus, the relationship 
between rates of responding and current levels after adminis­
tration of a 5-HT specific, MAO inhibitor was not a simple 
monotonie function.
This dissertation research focused on the specificity
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with which monoamines are released from the amygdala during 
rewarding ESB. Electrode placements in rats were behavioral- 
ly evaluated to determine the rewarding value of ESB. Iso- 
topically labeled 5“HT, isotopically labeled NE, and a con­
trol drug, isotopically labeled urea, were Injected into the 
lateral ventricle, and the amygdala was perfused during pre= 
sentation of the ESB or other sensory stimuli, namely a 
paired tone and light.
The following questions concerning the specificity of 
release of the biogenic amines with respect to drug conditions 
were investigated ;
(1) Is NE released during rewarding electrical sti­
mulation of the brain? A finding that NE is released in these 
circumstances would constitute a replication of part of the 
Stein and Wise (I969) study.
(2) Is 5~HT released during rewarding electrical sti­
mulation of the brain? Since other investigations have found 
5-HT to be systematically related to SS, a positive finding 
can be anticipated here,
(3) Does ESB also induce the release of a relatively 
neutral substance, urea? If so, concepts which advocate the 
monoamines as specific mediators of reinforcement on the basis 
of the Stein and Wise (I969) findings will be considerably 
challenged, and the method of examining released substances 
will require close scrutiny in order to determine how much 
the release might be due to an actual physiological release.
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and how much to other factors such as stress to the animals 
or physical Insult to their brains.
(4) Will simultaneous injection of both labeled NE 
and labeled 5-HT alter the results? It is desirable to in­
ject both monoamines simultaneously in order to examine pos­
sible interaction effects or possible differential involve­
ment of adrenergic and serotonergic systems while holding 
conditions of electrode placement and SS rates constant. Fur­
ther, it may be that injecting both NE and 5-HT produce 
changes in the amines or in the way in which they are ab­
sorbed and utilized.
Finally, the following questions concerning the spe­
cificity of release of biogenic amines with central and peri­
pheral stimuli will be investigated;
(1) Is the release of biogenic amines specific to
rewarding ESB or do other sensory stimuli (AVS), presumably 
neutral in their rewarding value, such as a paired tone and 
light, cause an analogous release? In other words, is it 
merely a non-specific property of stimuli which causes the 
release of biogenic amines, or is the release contingent upon 
rewarding ESB?
(2) Does the current level of the ESB affect the re­
lease of the monamines? One might expect that the higher the 
current (within certain limits), the greater the amount of 
monoamines released.
CHAPTER II 
METHODS
General Design of the Research 
Table 1 presents the design of the research. There 
are four categories of isotopically labeled substances 
which were injected into the lateral ventricle of rats prior 
to amygdaloid perfusion. One group (NES) had only NE 
injected, a second group (5-HTS) had only 5-HT injected, a 
third (NE+5-HT) had both NE and 5-HT injected simultaneously, 
and the last group (US) had only urea (U) injected. The 
first two groups (NES and 5-HTS) were used to examine the 
release of these amines during ESB and also during auditory 
and visual stimulation (AVS). The third group (NE+5-HT) 
was used to examine possible interaction effects of the two 
amines, while holding the electrode placement and rewarding 
value of the ESB constant. The last group (US) was used as 
a control to examine the chemical specificity of the release 
phenomenon and to investigate the possibility that any release 
of the biogenic amines was an artifact due to some aspect 
of the electrical stimulation other than induction of 
neuronal firing.
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TABLE 1
GENERAL DESIGN OF THE RESEARCH
Rewarding
(R)
Non-
Rewarding
(NR)
Control or 
background 
release
(c)
H^norepi-
nephrlne
(NES)
N=4 N=2 N=0
H3serotonln
(5-HTS) N=2 N=2 N=0
H3norepi-
nephrine
cl^serotonln
(NE+5-HT)
N=4 N=2 N=3
C^^nrea
(US) N=4 N=0 N=1
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The two categories of rewarding (R) or non-rewarding 
(NR) ESB were determined during behavioral testing one to 
five days prior to perfusion. A third group, background (B) 
release, was given no ESB and no AVS during the perfusion in 
order to examine the nature and shape of the release curve 
under conditions of minimal stimuli. Table 1 also lists the 
number of rats in each condition.
Some of the data from the NES,R group and the NES,
NR group represent a replication of the research reported 
by Stein and Wise (1969). The other groups represent 
original research.
Subjects and Surgery
Subjects were male rats of the Sprague-Dawley 
(Schmitt) strain implanted with bipolar stainless steel 
electrodes (0.008 inches in diameter) in the MFB under 
pentobarbitol anesthesia (50 or 60 mg/kg) approximately 
one to four weeks prior to behavioral testing. In each 
animal, a stainless steel push-pull guide cannula (18 gauge 
tubing) also was implanted in the amygdala and a stainless 
steel injecter guide cannula (22 gauge tubing) was implanted 
in the lateral ventricle. All implants (obtained from 
Plastic Products, Roanoke, Va.) were on the left side. The 
stereotaxic coordinates for the electrode varied somewhat 
but two placements were routinely used: 1) with incisor bar 
elevation at the level of the intra-aural line, the place­
ments were 3»5 mm posterior to bregma, I.3 to 1.7 mm lateral
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from the midline, and 8.5 mm down from the top of the skuH, 
and 2) using deGroot (1959) reference points the placement 
was AP +3.8, V -3»5t and L 1.3» The push-pull placement
with deGroot (1959) reference points was AP +5.0, V -2.5,
and L 4.0. The injecter cannula placement was AP 6.0,
V +3.1, and L 1.4. Figure 4 (a) illustrates the implanted 
electrode and cannulae with accompanying apparatus neces­
sary to use them.
Behavioral Evaluation 
After the surgical recovery period of one to four 
weeks, the electrode sites were evaluated for R or NR using 
operant techniques. Ten animals received training in a 
Skinner box where delivery of an ESB was contingent on a 
lever press. Learning the lever-press response and 
asymptotic rate of responding was the index of R or NR for 
these animals. Fourteen animals were tested in a runway 
equipped with photocells. The animal received ESB when the 
designated photo cell at one end of the runway was broken. 
The ESB continued at the rate of one per second until the
animal broke another photocell. The end of the runway
where ESB was received was systematically varied to ensure 
the animal was not merely exibiting an end-position prefer­
ence. Testing was done primarily in five-minute sessions. 
Only those sessions in which the animal sampled both the ESB 
end and the other non-stimulation end of the runway were 
included in the behavioral analysis. The per cent of time
Figure ^ - Chronically implanted apparatus, (a) Shows from left to 
right a skull cap, the injecter cannula, the electrode, and the push-pull cannula. 
Each Implant Is shown assembled as It Is used, (b) Shows the component parts of 
the electrode assembly. From left to right, a skull cap, the electrode as it is 
supplied from Plastic Products, Inc., the electrode cut off ready for implantation, 
the electrode connector, and the electrode cap. (c) Shows the components of the 
injecter cannula. From left to right a skull cap, the guide cannula which is 
implanted into the brain, the internal cannula, the internal cannula incerted into 
the guide cannula ready for isotope injections, and the dummy cannula. (d) Shows 
the component parts of the push-pull cannula assembly. From left to right the 
push cannula with connector, the pull cannula, the push and pull cannula screwed 
together, the push-pull cannula assembly after it has been sealed to prevent 
leaking and screwed into the guide cannula, and the push-pull cannula inserted into 
the skull cap.
wFigure 4
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the animal spent in the ESB end of the runway was taken as 
an index of R or NR. The ESB parameters were: train 
duration = 100 msec., pulse frequency = 100 cps, and mono- 
phasic pulse duration =0.2 msec. The current was varied 
for each animal based on his behavior and ranged from 50 
microamps to 450 microamps. Figure 5 (a) shows an animal 
in the runway testing apparatus.
Injection of the Radio-Isotoues 
and Hypothalamic Perfusion
On the perfusion day the animal was placed in the 
restraining device shown in Figure 5 (b) and received lateral 
ventricle injections of trace amounts of either H^NE, h35-HT, 
both H^HE and C^^5“HT, or (Amersham-Searle), Figure
5 (c) illustrates the injection proceedure. Amounts of the 
compounds injected varied from 1.55 micrograms to 3.8? micro­
grams for NE, from 0-03 milligrams to 0.06 milligrams for 
5-HT, and from 10 micrograms to 15 micrograms for U. Volumes 
injected were either 20, 30» or 50 microliters of solution.
Recent studies (Glowinski & Iversen, 1966; Iversen
6 Glowinski, 1966; Palaic, Page, and Khairallah, 196?;
Axelrod & Inscoe, 1963; and Chase, Katz, & Kopin, 1969) have 
demonstrated that labeled NE and labeled 5-HT injected in 
this manner mix with the endogenous stores and are probably 
released in a manner analogous to the naturally occurring 
monoamines.
Forty-five minutes after the ventricle injection, the
Figure 5 - An animal during behavioral testing and push-pull perfusion.
(a) Shows the rat in the evaluation runway. It is remaining in the end of the 
runway where it is receiving ESB at the rate of one train every second. (b) Shows 
the animal which has been placed in the restraining device prior to isotope 
injection. The device allows some movement while the animal's head is relatively 
immobile and is easily accessible. (c) Shows the animal being injected with 
trace amounts of H%E. (d) Shows the rat during push-pull perfusion. The 
electrode connector and the push-pull cannula have been screwed in.
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animal was placed in a dimly iLltiminated and sound 
attenuated chamber. The tubing of the push and pull can­
nulae were attached to syringes on a Harvard infusion- 
withdrawal pump and the flow of the solution through the 
push-pull cannula was initiated and checked for uniformity 
of flow. The push-pull cannula was inserted into the guide 
cannula and perfusion of the amygdala was begun. Figure 5 
(d) shows an animal being perfused.
The push-pull cannula (seen in figure 6) consisted of 
concentrically arranged 22 and 28 gauge stainless steel 
tubing. Locke-Ringer*s solution flowed down the inner tube 
under positive pressure, was exposed to the amygdaloid 
tissue, and flowed up the outer tube under negative pressure.
A portion of the released neurohumor is picked up in the 
solution and carried out the push-pull cannula to be collected 
in a syringe on the pump. The rate of perfusion was 0.15 ml 
per minute or 9 ml per hour.
The amygdala was perfused in this manner for a 
period of five to seven hours. For all animals, except 
those in the group receiving no stimuli during perfusion, 
there were three stimulation treatment periods, each lasting 
approximately 45 minutes. During the first of these (ESB-1), 
animals were given ESB at a train rate of one per second 
using the same parameters as during the behavioral evaluation 
proceedure. The current was set slightly higher than thres-» 
hold level. During the second stimulation period (ESB-2) all
Figure é - Construction of the push-pull cannula. During the perfusion 
the push-pull cannula shown on the left is inserted and screwed into the chron­
ically implanted guide cannula shown on the right. Locke-Ringer*s solution 
is infused through the push or inner cannula under positive pressure. The fluid o
is exposed to brain tissue at the tip of the cannula and picks up released 
neurohumorsc The solution is then withdrawn through the pull or outer cannula 
under negative pressure.
INFUSION WITHDRAWA L \
<r-PULL CANNULA 
26 gauge stain less  
s te e l tub ing
^GUIDE CANNULA 
19 gauge thin^  
>^§1l sta in less  
steel tu b in g
PUSH c a n n u la -  
22 gauge stainless 
stsef tu b in g
Figure 6
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animals were given the same ESB trains but at a higher 
current intensity. During the last stimulation period 
(AVS) animals were subjected to intermittent lights and 
tones at the same rate they received the ESB. For all 
animals except three which were in the NES,H group the 
stimulation periods alternated with background control 
periods (b) of no stimulation, also lasting approximately 
45 minutes. The other three animals received one hour B 
control periods before and after the three sucessive 
stimulation treatment periods.
During the perfusion, samples of the perfusate were 
collected every fifteen minutes. Five hundred microliters 
of each sample was added to 13 ml of Triton X-100 counting 
solution and was counted in a liquid scintillation counter 
to determine the amount of radioactivity present in each 
sample.
Occasionally during the perfusion of some animals 
the cannula would cease to function properly because of 
clogging, producing a reduction in the rate of flow of the 
solution. When this occurred the push-pull cannula was 
removed, cleaned and reinserted. After perfusion was 
restarted the treatment condition underway at the onset of 
flow retardation was usually reinitiated.
At the end of the perfusion period all animals were 
perfused with formalin. Later, the brains were removed and 
histological examination of the location of the implants 
was performed on all animals.
CHAPTER III 
RESULTS
The data will be examined first for individual 
animals, second for general characteristics of the back­
ground release function, third for differences in release 
induced by stimulation in the single and double labeled 
groups, and finally for stimulation effects in the labeled 
groups combined.
Correction of Data 
Each sample obtained from the push-pull cannula 
perfusion was counted in a liquid scintillation counter.
The results were corrected for quenching. In addition 
where the sample time deviated slightly from the nominal 
fifteen minutes the data were corrected to a standard 
sampling period of fifteen minutes. Data were also corrected 
for the exact amount of perfusate obtained in each sample if 
the amount differed from the standard 2.2 ml.
Individual Results 
Figures 7"9 present raw data from representative 
individual animals in counts per minute (CPM) to illustrate 
the overall shape of the release curves of the injected
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Figure 7 - Individual results of an animal in the 
rewarding group: NE & 5-HT. This is a plot of the raw data 
in CPM of animal # BA-37* This animal spent 82% of its 
time in the ESB side of the evaluation runway when the 
current was set at 15O microamps. It was injected with 
20 microcuries (1.55 micrograms) of H % E  and 4.6 microcuries 
(0.03 milligrams) of C^^5“HT. During the ESB-1 stimulation 
period when the current was set at 150 microamps a slight 
potentiation of release of NE and inhibition of release of 
5-HT can be seen. During the ESB-2 stimulation when the 
current was set at 200 microamps there was a potentiation 
of release of both NE and 5“HT. During the AVS period when 
lights and tones were presented there was very little 
release or inhibition of release of NE or 5-HT.
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Figure 8 - Individual results of an animal in the 
non-rewarding group: 5-HT. This is a plot of the raw data 
in CPM of animal # B-51. This animal spent Z2% of its time 
in the ESB side of the evaluation runway when the current 
was set at 150 to 400 microamps. It was injected with 
75 microcuri.es (O.O6 milligrams) of H^S-HT. During both 
the ESB-1 period with the current set at 250 microamps 
and ESB-2 with the current set at 300 microamps there was an 
inhibition of release of 5-HT. During the AVS period when 
lights and tones were presented there was no release or 
inhibition of release.
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Figure 9 - Individual results of an animal in the 
rewarding group: urea. This is a plot of the raw data in 
CPM of animal # C-44. This animal spent 86^ of its time 
in the ESB side of the evaluation runway when the current 
was set at 250 microamps. In addition its asymptotic self­
stimulation rate was 3220 responses per hour when the 
current was set at 300 microamps. It was injected with 
10 microcuries (lOmicrograms) of urea. There was no release 
or inhibition of release of urea during either the ESB-1 
or ESB-2 stimulation periods with the current set at 250 
and 300 microamps respectively, A slight inhibition of 
release of urea is apparent during the AVS stimulation 
period when lights and tones were presented.
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compounds. Figure 7 presents the data obtained on an 
animal injected with both H^NE and C^^5~HT in the R group. 
This animal had spent 82 per cent of the time in the 
evaluation runway on the side which delivered ESB (current 
intensity set at 150 microamps). The total amount of H^NE 
injected was 1.55 micrograms while the total amount of C 
5-HT was 0.03 milligrams. This figure illustrates that 
there was a rapid fall in the background rate of release of 
both NE and 5-HT, presumably due to the radioisotope’s 
disappearance from the CNS, The background release for this 
subject is nearly linear and the mean CPM is low (604 with 
a standard deviation of 1?6 for NE, and 425 with a standard 
deviation of 139 for 5-HT). It can be seen that the curves 
for NE and 5-HT are very similar. It should be noted that 
during the ESB-1 period when the current Intensity is close 
to threshold for rewarding effects there appears to be a 
slight potentiation of NE release and a slight inhibition 
of 5-HT release. During the ESB-2 period, however, with the 
current 50 microamps higher, there is substantial release of 
both 5-HT and NE. During the AVS period there appears to be 
a slight inhibition of NE and a slight release of 5-HT over 
background levels.
Figure 8 presents the data obtained on an animal 
injected with H^5-HT in the NR group. This animal’s 
electrode was classified as NR because he had spent only 
22 per cent of his time on the ESB side of the evaluation
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runway where current intensities ranged from I50 to
400 microamps. He was Injected with O.O6 milligrams of 
3
H 5-HT. Again there is a rapid fall in the background rate 
of release. The mean level of CPM is much higher than in 
the proceeding animal (39»789 and a standard deviation of 
61,941). It should be noted that data for this animal are 
plotted on a logarithmic scale because the rate of background 
release changes considerably over time. When plotted in 
this manner, the log-rate of background release is nearly 
linear over time. There appears to be an inhibition of 
release of 5-HT during both ESB-1 and ESB-2 but not during 
AVS.
Figure 9 presents the data obtained on a control 
animal injected with in the R group. This animal was
tested in both the Skinner box bar-press task and in the 
evaluation runway. He had spent 86 per cent of the time on 
the ESB side of the runway (at a current intensity of 25O 
microamps). In addition his rate of SS was 3220 responses 
per hour (at 3OO microamps current intensity). Again the 
rate of background release changes over time but is nearly 
linear when plotted on a logarithmic scale. The mean level 
of CPM was also high in this animal (25,899 with a standard 
deviation of 49,459). Neither the ESB-1 nor ESB-2 caused 
detectable potentiation or inhibition of release but during 
AVS, a slight inhibition of release may have occurred.
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Grouped Data
In general, when an animal was injected with both 
NE and 5“HT the background release declined faster for 5-HT 
than for NE, and in most cases there was an exponential 
decline in the rate of release for both amines.
Nature of Background Release 
Figure 10 is a graph of all background points 
averaged over all animals. The data are portrayed in three 
different ways. First, there is a plot of raw CPM scores 
converted to standard scores. Second, there is a seml-log- 
arithmic plot of the same data using the same standard 
scores on the y-axis and the log of *"he sample number (which 
is an index of time) on the x-axis. Third, there is a 
log-log plot using the logs of standard scores of CPM on the 
y-axis and the log of the sample number on the x-axis. The 
correlation coefficient for each line is also given. It is 
evident that the plot of standard scores vs. the sample 
number produces a curvilinear relationship. The semi-log­
arithmic plot produces a relationship nearly linear until 
the last point. The log-log plot is relatively linear when 
compared with the semi-log plot but is perhaps not as good a 
fit as the semi-log relationship. The correlation coefficient 
for the semi-log plot also indicates that it is probably the 
best fit in terms of a straight line, although the log-log 
relationship is virtually as good. Therefore, the rate of 
background release of these compounds is most probably a
53
Figure 10 - Three plots of background, control data.
For each of these plots every background data point for
every animal was included. The plot keyed as "raw" refers 
to a plot of the raw standard scores on the y-axis vs. the 
sample number (an index of time) on the x-axis. The plot 
keyed as "Semi-log" refers to a plot of the raw standard 
scores on the y-axis vs. the log of the sample number on 
the x-axis. The plot keyed as "Log-log" refers to a plot 
of the log of the raw standard scores on the y-axis vs, 
the log of the ss,mple number on the x-axis. The R’s 
indicate that the Semi-log plot is probably the best fit of 
the data for a straight line. It is apparent that it is
the best fit especially for the first three points.
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semi-logarithmic one.
Plots of Means 
Figures 11-13 are graphs of the means of standard 
scores of CPM per sample of perfusate. First the CPM 
scores for each animal were converted to standard scores. 
Then the mean of the standard scores for each treatment in 
the R,NR, or control groups was determined. It is evident 
that during ESB-2 for the R group, release of both NE and 
5-HT was potentiated. In addition, it appears that there 
was an inhibition of release for ESB-2 in the NR groups.
To evaluate the statistical significance of these treatment 
effects, residual change scores were computed for each 
animal, for each treatment condition.
Expected Minus Observed Difference Scores 
(Residual Change Scores)
Due to the large variation in the level of CPM 
between animals and the exponential disappearance of the 
compounds from the CNS, standard scores for each animal were 
derived from the distribution represented by the three 
samples of the control period prior to the stimulation 
period (C]_), the three samples during the stimulation 
period (S), and the three samples of the control period 
after the stimulation period (Cg). The mean of the before 
and after control periods was taken as an expected score,
E = Cg , Difference scores were then computed between
56
Figure 11 “ Plots of the means of standard scores
of CPM for each group and. treatment for NE. Mean = 0,
S.D. = 1.0
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Figure 12 - Plots of the means of standard scores
of CPM for each group and treatment for 5-HT. Mean = 0,
S.D. = 1.0
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PigTixe 13 - Plots of the means of standard scores
of CPM for each group and treatment for urea. Mean = 0,
S.D. = 1.0
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the expected and observed means Dr = S - E. A positive 
residual change score indicates potentiation and a negative 
score indicates inhibition of release of a compound. The 
t test was used to assess the significance of the observed 
minus expected or residual change scores (D^).
Single vs. dual labeled data. Figures 14 and 15 
present the scores and standard errors for the three 
treatment conditions ESB-1, ESB-2, and AVS for single vs. 
dual labeled animals (NES vs. NE+5-HT for NE and 5-HTS vs. 
NE + 5-HT for 5-HT). Figure 14 shows the data for R 
placements and figure 15 shows data for NR placements.
Zero mu t tests for these data indicate that the only 
significant effects were an inhibition of release of 5-HT 
during ESB-1 for the R, dual labeled group; release of NE
during ESB-2 for the R, single labeled group; and an
inhibition of release of NE for the NR, dual labeled group.
T tests for independent means indicate that there 
was no significant difference for any dual vs. single 
labeled group during any ESB period (t for ESB-1, NE, R 
= 1.06, df = 5; t for ESB-2. NE, R = 0.25, df = 6; t for 
ESB-1, 5-HT, R = 0.84, df = 3; t for ESB-2. 5-HT, R =
-0.09, df = 4; t for ESB-1, NE, NR = 2.77, df = 2; not
computable for ESB-2, NE, NR; t for ESB-1, 5-HT, NR, =
3.09, df = 2; t for ESB-2, 5-HT, NR = -0.10, df = 2). 
Therefore in further data analysis the single and dual 
labeled data for any one amine were combined and treated as
Figure 14 - Expected minus observed difference scores (residual change 
scores) for sin^e vs. dual labeled animals for rewarding groups. *p<0.10,
o\
**p<0,05 Numbers in parentheses indicate the number of animals in each group.
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one group.
Combined data. Table 2 presents the combined data
(Dp) for each group, the number of subjects in that group,
the standard error of the mean difference, and the zero mu
t with its level of significance. The same data are repre­
sented in figures 16-18.
Combined data: zero mu t tests. In the R group 
there was a significant release of NE during ESB-2 at the 
higher current intensity, but not during ESB-1 when the 
current intensity was only slightly above threshold levels 
for rewarding effects.
There was a significant release of 5“HT during ESB-2 
and contrary to the expected result, a significant Inhibition 
of release of 5-ET during ESB-1 at the lower current level.
In the NR group there was a significant inhibition of 
release of both NE and 5-HT during both ESB-1 and ESB-2. No 
significant changes in the perfusate radioactivity of any 
compound were obtained during the AVS. Further, any increases 
or decreases in the perfusate radioactivity of U during 
ESB-2 and ESB-1 respectively were not significantly different 
from zero.
For the control groups there was a significant inhibi­
tion of release for ESB-1 for both NE and 5-HT. As will be 
discussed later, this inhibition may be more apparent than 
real. No other stimulation period produced any significant 
differences.
Combined data: R vs. NR. Table 3 presents the data
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TABLE 2
RESIDUAL CHANGE SCORES (D?) FOR TREATMENT 
CONDITIONS FOR EACH COMPOUND
Number
of
Animals
Mean
Standard 
Error 
of the 
Mean 
Difference
Zero
Mu
T
NE.R,ESB-1 7 -0.03 0.26 -0.12^
NE.R,ESB-2 8 0,78 0.23 3.41^
NE,R,AVS 6 -0.22 0.14 -1.56
5-HT,R,ESB-1 5 -0.58 0.10 -5.72%
5-HT,H,ESB-2 6 0,66 0.23 2.840
5-HT,R,AVS 4 0.04 0.06 0.63
NE,NR,ESB-1 4 -0.4? 0.17 -2.4lb
NE,NR,ESB-2 3 -0.97 0.21 -4.59*
NE,NR,AVS 3 -0.39 0.21 -1.80
5-HT ,NR,ESB-1 3 -0.53 0,21 -2.58%
5-HT ,NR, ESB-2 4 -Oc 97 0.21 3.14°
5-HT,NR,AVS 4 -0,33 0.25 -1.35
U,R,ESB-1 4 -0.16 0.31 -0.54
U,R,ESB-2 4 0.52 0.28 1.83
U.R.AVS 4 0.31 0.55 0.57
NE,C,ESB-1 3 -0.53 0.05 -9.82°
NE,C,ESB-2 2 -0, 02 0.44 -0.06
NE,C,AVS 1 0.19
5-HT,C,ESB-1 3 -0.42 0.07 -6.2lf
5-HT,C,ESB-2 2 0.04 0.43 0.07
5-HT,C,AVS 1 -0.71
U,C,ESB-1 1 0.40
U,C,ESB-2 1 -0.47
U.C.AVS 1 -1.29
®p<0.10, ^p<0.05, ®p<0.025, (^p<0.01 for one-tailed test
®p<0.10, ^p<0.05, Sp<0.02, ^p<0.01 for two-tailed test
Figure 16 - Expected minus observed difference scores (residual change 
scores) for all groups for the first stimulation period (SSB~1). **p<0.0^,
***p<0.02, ****p<0.01 Numbers in parentheses indicate the number of animals in o\
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scores) for all groups for the third stimulation period (AVS). None of the 
differences are significant. Numbers in parentheses ircdcate the number of 
animals in each group.
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TABLE 3
T*S FOR BETWEEN GROUP COMPARISONS
Comparison df t P
R vs. NR
NE, ESB-1 9 1.50 <0.10
NE, ESB-2 9 5.62 <0.0005
5-HT, ESB-1 7 -0.59 N.S.
5-HT, ESB-2 7 5.19 <0.005
NE,R & 5-HT,R vs. U,R
NE vs. U, ESB-1 9 0.34 N.S.
NE VS. U. ESB-2 10 0.71 N.S.
5-HT vs. U. ESB-1 7 -1.30 N.S.
5-HT VS. U, ESB-2 8 0.39 N.S.
ESB vs. AVS
NE, R, ESB-1 k 0.28 N.S.
NE, R, ESB-2 5 5.04 <0.005
5-HT, R, ESB-1 2 -5.03 <0.025
5-HT, R, ESB-2 3 1.91 <0.10
NE, NR, ESB-1 4 -0.03 N.S.
NE, NR, ESB-2 3 -1.46 N.S.
5-HT, NR, ESB-1 3 -0.45 N.S.
5-HT, NE, ESB-2 3 -0.77 N.S.
ESB-1 vs. ESB-2
NE, R 7 -3.42 <0.02
5-HT, R 4 -4.03 <0.02
NE, NR 4 4.79 <0.01
5-HT, NR 4 -0.36 N.S.
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TABLE 3—  Continued
Comparison df t P
NE & 5-HT vs. Control (C) 
NE, R vs. C, ESB-1 8 1.91 <0.10
NE, R vs. C, ESB-2 8 1.39 <0.20
5-HT, R vs. C, ESB-1 6 -1.37 N.S.
5-HT, R VS. C, ESB-2 6 1.29 N.S.
NE, NR vs. C, ESB-1 5 -0.38 N.S.
NE, NR vs. C, ESB-2 3 -1.9^ <0.20
5-HT, NR vs. C, ESB-1 5 -0.5^ N.S.
5-HT, NR vs. C, ESB-2 4 -1.39 N.S.
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for between group comparisons. T tests for independent 
means indicate that there was a significant difference 
between the B group displaying NE release and the NR groups 
displaying inhibition of NE release for ESB-2. The level 
of significance for ESB-1 for the same comparison approached 
but did not reach statistical significance.
Likewise there was a significant difference between 
the R group displaying 5-HT release and the NR group dis­
playing inhibition of 5“HT release for ESB-2 but not for 
ESB-1.
Combined data: NE & 5-HT vs. Urea. Contrary to 
expectations, there were no significant differences between 
NE, R and U, R groups or between 5-HT, R and U, R groups for 
any treatment.
Combined data: ESB vs. AVS. For the NE and 5-HT, R 
groups there was a significant difference between the ESB-2 
periods, displaying release, and the AVS periods. For 5-HT,
R groups the difference between ESB-1 periods displaying 
inhibition of release, and AVS periods was also significant. 
In the NR group none of the ESB vs. AVS comparisons were 
significant.
Combined data; ESB-1 vs. ESB-2. There was a signif­
icant difference between ESB-1 and ESB-2 periods for the NE,
R and 5-HT, R groups with ESB-2 showing more release.
For the NE, NR group there was a significant differ-
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ence between ESB-1 and ESB-2 with a greater inhibition of 
release during ESB-2. For the 5-HT, NR group there was no 
significant difference between ESB-1 and ESB-2. Both showed 
inhibition of release.
Combined data;NE & 5-HT vs. Control. For the NE, R 
group the release of NE over control group levels only 
approached significance, no other comparisons with control 
groups indicated any significant differences, perhaps due to 
the small number of animals in each group.
NE vs. 5-HT. Because of the mixture of correlated 
and uncorrelated scores for the NE and 5-HT treatments, the 
data cannot be combined to perform single t tests to determine 
the statistical significance of any differences between these 
groups. Therefore separate t tests were carried out on the 
correlated and uncorrelated data. None of the t tests 
indicated any significant differences between NE and 5-HT 
groups for any treatment. One comparison between NE,R and 
5-HT,R for ESB-1 approached significance (t = 1.94, df « 4, 
pcO.lO). It is likely that with a larger N the difference 
might have been significant.
Combined data: non-narametrie tests. In order to 
further access the magnitude of the treatment effects the 
Walsh test was used. This non-parametric test utilizes both 
the magnitude and sign of the difference scores. Table 4 
presents the Dj. scores for each animal in each group and the
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TABLE 4
INDIVIDUAL D« SCORES IN EACH GROUP AND 
RESULTS OF THE WALSH AND SIGN TESTS
Scores
in
Group
Walsh
Test
P
Sign
Test
P
Scores
in
Group
Walsh
Test
P
Sign
Test
P
NE,R,ESB-1  
-0.58  
-0.54  
-0.51  
-0.31  
+0.17 
+0.25  
+1.31
N.S. 0.500 5-HT.R.ESB-1  
"0.91  
—0.68 
-0.54 
-0.50 
-0.29
<0.062 0.031
NE,R, ESB-2  
-0.12  
+0.02  
+0.56 
+0.65 
+0.89
+1.14
+1.44
+1.67
<0.012 0.035 5-HT, R, ESB-2
+0.03
+0.31
+0.44
+0.52
+1.07
+1.59
<0.016 0.016
NE.R,AVS
—0*54
-0.53
-0.44
-0.09
+0.02
+0.28
N.S. 0.344 5-HT.R, AVS
-0.13 
+0.03 
+0.11  
+0.14
N.S. 0.25
NE,NR, ESB-1  
"0.75  
-0.72 
"0.39  
-0.003
<0.062 0.0625 5-HT,NR,ESB-1 <0.62  
-1.00  
-0.72 
-0.36 
-0.05
0.0625
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TABLE ^— Continued
Scores
In
Group
Walsh
Test
P
Sign
Test
P
Scores
in
Group
Walsh
Test
P
Sign
Test
P
NE,NR,ESB-2 
-1.39 
-0.77 
-0.74
0.125 5-HT,NR,ESB-2 <0.62 
-1.08 
-0.77 
-0.54
-0.13
0.0625
NE,NR,AVS
-0.79
-0,32
-0.05
0,125 5-HT,NR,AVS 
-0.78
-0.53
-0.38
+0.37
N.S. 0.25
Ü,R,ESB-1 
-0.75 
•rO.55  
+0.03 
+0.61
N.S. 0.50 U.C, ESB-1 
+0.40
U,R,ESb-2
-0.14
+0.27
+0.83
+0.83
N.S. 0.25 U,C,ESB-2
-0.47
U.R.AVS
-0.76
-0.38
+0.75
+1.63
N.S. 0.50 U,C,AVS
+1.29
NE, C.ESB-1 
-0.62 
-0.54
-0.43
0.125 5-HT,C,ESB-1
-0.54
-0.40
-0.31
0.125
NE,C,ESB-2 
—0.46 
+0.41
0.50 5-HT,C,ESB-2 
-0.40 
+0.46
0.50
NE,C,AVS 
-0.19
5-HT,C,AVS 
-0.71
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level of significance as determined by the Walsh test. In 
addition results of the non-parametric sign tests are given. 
For the NE, R group only three of the seven scores 
indicate potentiation of release of NE for ESB-1 while seven 
of the eight scores indicate release for ESB-2, However, for 
the 5-HT, R group all five scores for the ESB-1 treatment 
indicate inhibition of release, and all six scores for the 
ESB-2 treatment indicate release of 5-HT. Therefore it 
appears that the effects for 5-HT are more consistent than 
they are for NE for the R groups although the difference is 
not great for ESB-2.
For the NR groups the signs of every score in every 
ESB treatment condition for both NE and 5-HT is negative 
indicating a very consistent inhibition of release of both 
NE and 5-HT.
None of the treatments in the U,R group had a 
significant effect. The signs for these groups are all 
mixed indicating no consistent effects.
Again none of the AVS treatment periods indicate any 
significant effects and the signs are mixed except for the 
NE, NR, AVS group in which all signs are negative with only 
three scores in that group.
For the control groups for the ESE-1 treatment 
period all scores are negative with only three scores in each 
group but for the ESB-2 treatment period the signs are mixed.
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Histology
Figure 19 shows the placements of electrodes for all 
animals except one non-stimulation control animal whose 
electrode was apparently bent laterally. The brain tissue 
of this animal was damaged by removing the skull cap and 
exact histological location of the electrode tip was 
impossible. One KR electrode located in AP 4.0 was almost 
through the brain tissue.
Photographs of representative sections for some of the 
animals are shown in figure 20. Figure 20 (a), (b), and (c) 
show sections of animal BA-37 whose data were represented in 
figure 7* Part (a) shows the injecter cannula which does 
not quite reach the lateral ventricle and probably explains 
the low level of overall activity for this animal. This 
section also shows the placement of the push-pull cannula. 
Section (b) further shows the placement of the push-pull 
cannula, and section (c) shows the electrode placement. A 
typical lateral ventricle placement is seen in section (d).
It is from animal C-44 whose data are represented in figure 
9. Sections (e) and (f) show other typical placements of 
the push-pull cannula. Section (e) is from an animal 
injected with 5"HT in the R group and section (f) is from an 
animal injected with both NE and 5“HT in the NR group.
83
Figure 19 - Placements of the electrodes. All 
electrode placements (except one which is explained in the 
text) are indicated in this figure. Adapted from Pellegrino 
and Cushman (196?)
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Figure 20 - Photographs of representative rat brain 
sections, (a) (b) and (c) illustrate the injecter cannula 
placement, the push-pull cannula placement, and the 
electrode placement respectively for animal # BA-37 whose 
raw data are presented in Figure 7. (d) is the placement of
the injecter cannula for animal C-44 whose raw data are 
presented in Figure (e) and (f) show the placements of 
push-pull cannulas in two other animals. Magnification =
X3 3/4
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Figure 20
CHAPTER IV 
DISCUSSION
General Discussion of the Results 
The most consistent and significant findings of this 
research are that during periods of stimulation with higher 
current intensities, there was a significant potentiation in 
the release of both ME and 5-HT in animals receiving 
rewarding (or reinforcing) ESB as determined by prior 
behavioral testing. Furthermore, during these stimulation 
periods there was also a significant inhibition of release of 
both NE and 5-HT for animals receiving non-rewarding (or non- 
reinforcing) ESB.
During stimulation periods with lower current 
intensities there was no consistent potentiation in the 
release of NE with rewarding ESB. However, there was a 
consistent, statistically significant inhibition of release 
of 5-HT. In addition, there was an inhibition of release 
of both NE and 5-HT during stimulation periods with lower 
current intensities for animals receiving non-rewarding ESB. 
Furthermore, there was no statistically significant or 
consistent potentiation or inhibition of release of either 
NE or 5-HT during auditory and visual stimulation. Finally,
87
88
during rewarding ESB at either high or low current intensity 
there was no consistent or statistically significant change 
in the perfusate radioactivity of a control compound, urea.
Significant differences in NE and 5-HT activity 
were found between rewarding and non-rewarding stimulation 
groups during stimulation with higher current intensities. 
Additionally, for both biogenic amines there were significant 
differences between higher current intensity ESB periods and 
auditory and visual stimulation periods, and between the 
lower and higher current intensity ESB periods.
The failure to find significant release of NE during 
the lower current intensity stimulation period or differences 
between R and NR groups for NE during the lower current 
intensity stimulation period and between ESB during the 
lower current intensity stimulation period and auditory and 
visual stimulation may be due to either one or both of the 
following factors; (1) the lower current intensity does not 
reliably produce a potentiation of release of NE or (2) the 
rapidly declining, semi-logarithmic nature of the background 
rate of release of compounds during the initial stimulation 
period obscured any potentiation of release of NE. The 
latter possibility appears plausible. The only significant 
potentiation of release of NE or 5-HT in the non-stimulation 
control animals occurred, during the lower current intensity 
stimulation period and was an inhibition of release. Perhaps, 
then, all scores during the first stimulation period appear
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lower (due to the measuring technique) than they actually 
are. If this is the case, then the inhibition of release 
of 5-HT with R ESB during the lower current intensity 
stimulation period and even the inhibition of release of 
NE and 5-HT with NR ESB during this same period must take on 
less theoretical significance, and major theoretical 
considerations should be based on results obtained during 
the higher current intensity stimulation period.
The failure to find statistically significant 
differences either between the NE, H and U, R groups or 
5-HT, R and the U, R groups is probably due to the small 
number of animals in these groups. The trends are in the 
direction of more potentiation of release of NE and 5-HT 
than U and the effects are more consistent for NE and 5-HT 
than they are for urea. Likewise, the failure to find 
expected statisu.cally significant differences in poten­
tiation or inhibition of release of compounds between any 
NE or 5-HT group and the non-stimulation control groups 
probably is due to the small number of subjects in the 
control groups, especially for the higher current intensity 
stimulation period where the stimulated groups show the 
expected potentiation or inhibition of release but the 
control groups show inconsistent effects.
Specificity of Results 
The results of this research are consistent with 
the proposition that the rewarding effects of ESB are
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mediated by the biogenic amines, NE and 5**HT. The results 
indicate that the potentiation of release of NE and 5-HT 
are specific to rewarding ESB. The finding that NE is 
released more during ESB which has been shown to be rewarding 
to the animals than during background release periods 
replicated the Stein and Wise (1969) study. Furthermore, 
the potentiation of release of 5"HT during R ESB implies 
that 5“HT too is Involved in the reinforcing effects of ESB. 
The failure to find a consistent or statistically significant 
potentiation or inhibition of release of the control compound, 
U argues for the specificity of release of the biogenic amines 
examined in this research. In addition the non-release of U 
confirms that the push-pull cannula method can be a very 
useful tool in investigating brain-behavior relationships as 
it demonstrates that the technique itself does not cause a 
substantial release of a functionally non-significant com­
pound.
The findings that there were no differences between 
the data obtained from the singly or doubly labeled animals 
implies that the proceedure of injecting both amines 
simultaneously does not alter the results. This finding also 
demonstrates the usefulness of the push-pull technique when 
investigating behaviors which have been reported to be 
effected by both NE and 5“HT such as sleep patterns. The 
simultaneous Injection of both amines allows investigations 
of the diff erential involvement of the noradrenergic and
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serotonergic systems while holding treatment conditions 
constant within one animal.
The problem of incorporation of the biogenic amines 
into the endogenous stores bears on the interpretation that 
the release of both NE and 5~HT accompanies rewarding ESB.
As already cited a number of studies indicate that both 
NE and 5-HT injected in this manner do mix with the endog­
enous stores, but precise determination of the extent to 
which each store is labeled remains difficult. Some evi­
dence Indicates that noradrenergic sympathetic neurons 
are able to take up 5“HT as well as NE (Cooper, Bloom, &
Roth, 1970). If the central noradrenergic neurons also 
have this ability, it is possible that 5-HT injected into 
the ventricle could have been taken up by the noradrenergic 
as well as serotonergic neurons. This makes the interpreta­
tion of the release of 5-HT somewhat unclear. It is theoret­
ically possible that the release obtained during the ESB-2 
periods could have been due to NE containing neurons only. 
This possibility seems less likely, however, when the in­
hibition or release of 5-HT during the ESB-1 period is 
considered. The inhibition of release of the two amines 
was not parallel. There was a significant inhibition of 
release of 5-HT and no significant inhibition of release 
of NE, In addition, the comparison for the ESB-1 period 
for R stimulation in the single labeled group indicated 
a trend for a difference between NE and 5-HT activity (p<
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0.10). (Due to the experimental design the single and 
dual labeled scores could not be combined for these stat­
istical comparisons.) Since the inhibition or potentiation 
of release of these two amines was not completely parallel, 
it implies that more than one mechanism of release or in­
hibition of release was in operation. Thus, it seems 
probable that the release of the two amines during re­
warding ESB-2 does, at least in part, reflect potentiation 
of release from both NE and 5-HT containing neurons, and 
that this effect is functionally significant.
Another aspect of the uptake of compounds injected 
into the lateral ventricle concerns the uptake of a neurally 
nonfunctional compound such as U. While this compound is 
commonly used as a control substance in such studies, no 
proof of its uptake into any brain tissue exists. Thus 
although no significant release of U was obtained in this 
study, the absence of specific knowledge of its location 
within the cell makes it less than a perfect control 
compound. Perhaus the d isomer of NE which is apparently 
functionally inactive in the brain, would serve as a better 
control in further research of this tyr
The finding of potentiation or inhibition of re­
lease of NE and 5-HT during R or NR ESB respectively, and 
no potentiation or inhibition of release of these amines 
during auditory and visual stimulation is further substan-
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tlation that the potentiation and inhibition of release is 
contingent on R ©r NR stimulation and not due to a non-spe­
cific effect of stimuli.
The current intensity level profoundly affected the 
potentiation or inhibition of release of both NE and 5-HT,
The low current intensity produced no or relatively less 
potentiation or inhibition of release than did the higher 
current intensity for each group tested, and in one group 
(5-HT, E) the effect of Increasing current intensity 
apparently changed the inhibition of release of 5-HT to a 
relatively strong potentiation of release of this amine 
during the higher current intensity ESB, While for reasons 
discussed earlier, the inhibition of release of 5-HT during 
the lower intensity may be more apparent than real; never­
theless, there was a considerable change in the results 
depending on the current level for this amine. As will be 
discussed more fully after results of other studies are 
exarined, this considerable change in the behavior of 5-HT 
ith different current intensities could theoretically reflect 
a somewhat different role for 5-HT than for NE in reward 
mechanisms.
To summarize the results of this research with respect 
to specificity, the potentiation of release of both biogenic 
amines, NE and 5-HT, appears to be specific to rewarding 
ESB while the inhibition of release of NE and probably 5-HT 
is specific to non-rewarding ESB, The data support the
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proposition that there is both chemical specificity, as U 
did not show any potentiation of release during rewarding 
ESB and stimuli specificity, as the potentiation or inhibition 
of release depended on the rewarding properties of the ESB 
and auditory and visual stimulation produced no inhibition 
or potentiation of release of compounds. Furthermore the 
potentiation or inhibition of release depended on the current 
intensity of the ESB.
The specificity of these findings appears to 
eliminate the possibility that the release of amines is due 
to some nonspecific stress factor of the ESB. The opposite 
results for rewarding and. non-rewarding ESB argue against 
this hypothesis as well as the fact that auditory and 
visual stimulation produced no consistent results. In 
addition, if the potentiation of release were due to a 
stress factor, one would expect that the non-rewarding 
stimulation (which 3n some animals appeared to be very 
aversive) would produce a greater stress on the animal than 
would the rewarding ESB and thus should, have resulted in a 
greater potentiation of release of the amines than the 
positive ESB did.
In the remaining discussion the release of NE and 
5-HT will be assumed to be specific to the rewarding 
aspects of the ESB.
Biogenic Amines in Reinforcement 
Studies reported in the literature indicate that
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two different models with respect to the relationship of 
NE and 5-HT mechanisms to reinforcement are possible.
(1) Some evidence indicates that NE systems and 5-HT systems 
play opposite roles with respect to reinforcement mechanisms,
i.e., agonist and antagonist. (2) Other evidence indicates, 
however, that the two systems have similar or complementary 
effects on reinforcement mechanisms. In the following 
section of the discussion the evidence which bears on these 
two alternative hypotheses will be discussed with emphasis 
on three of the factors which appear to be important when 
considering 5-HT mechanisms in reinforcement: the current 
intensity, electrode location, and level of amines present 
in the brain and methods of inducing these levels.
NE Mechanisms 
Psychopharmacological and biochemical studies cited 
in the introduction and the findings of this research are 
consistent with the proposition that NE is involved specifi­
cally in reinforcement mechanisms and that a noradrenergic 
neural system controls rewarding or reinforcing behavior. 
Manipulations which potentiate noradrenergic effects 
consistently increase 88 behavior while those manipulations 
which have antagonist effects to NE decrease 88 behavior. 
Moreover, as long as the stimulating electrode is in a 
rewarding area the specific electrode location or the current 
intensity usually does not interact with manipulations of 
CNS noradrenergic levels to produce differential effects
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on SS behavior.
The potentiation of release of NE found in this 
study may reflect the fact that reinforcement mechanisms 
are under the control of neural pathways which employ NE 
as the primary neural transmitter. Thus, the potentiation 
of release of NE with rewarding stimulation is due to the 
increase in firing of neurons within this neural system.
5“HT Mechanisms 
The finding of this research and other studies 
cited in the introduction and below indicate that the 
relationship of 5“HT mechanisms to reinforcement processes 
may not be as simple and direct or potent as it is for NE. 
Although none of the differences between NE and 5“HT in 
this research are statistically significant, the trend 
appears to be for greater release of NE during rewarding 
ESB and greater inhibition of release of NE during non-re­
warding ESB than for 5-HT. In addition there are conflicting 
reports in the literature of the role of 5-HT systems in 
reinforcement mechanisms.
Stein (1971) found that 5-HT injected into the lateral 
ventricle reduced SS rates to forty or fifty per cent of the 
pretreatment level. This result as well as that of Wise, 
Berger, and Stein (1970) which reports that increasing brain 
levels of 5-HT potentiated conditioned suppresion of drinking 
while reduced levels of brain 5-HT reduced conditioned 
suppression of drinking, led Stein to postulate that 5-HT
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mediates suppression of goal directed behavior while KE 
mechanisms mediate its release. Thus, Stein views NE and 
5"HT systems as having opposite effects on reinforcement 
processes.
A recent study by Poschel and Ninteman (1971) in 
which brain levels of 5"HT were reduced with p-chloro- 
phenylalanine reported excitatory effects on SS behavior, 
a result opposite to their earlier findings. This excitatory 
effect was especially pronounced with electrode placements 
in the ventral tegmental area of Tsai or the MFB. No such 
effect was found in the dorsomedial hypothalamus or the 
midbrain reticular formation. These investigators postulate 
reciprocal effects of NE and 5-HT on reinforcement behavior, 
such that NE acts to increase and 5-HT to decrease the 
excitability of the reward system. They do emphasize, 
however, that at any given time level of excitation depends 
on the balance of the two amines and. not just the presence 
of sufficient brain levels of NE.
An earlier study by Poschel and Ninteman (I968) 
found that after M O  inhibition by pargyline, 5-hydroxytryp- 
tophan (the precursor of 5-HT) produced excitatory effects 
on SS behavior, a result which argues against the position 
that 5-HT systems are antagonistic to SS behavior. They 
further reported that other investigators have found 
inhibitory effects on behavioral responding after administer­
ing pargyline followed by higher doses of 5-hydroxytryptophan
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than were used in the Poschel and Ninteman (1968) study.
Thus, it could very well toe that effects of 5-HT mechanisms 
on SS and other behavioral responding are dose specific, 
i.e., very sensitive to the specific levels of 5-HT in 
the CNS.
As discussed in the introduction, the Stark, Boyd, 
and Fuller (1964) research clearly implicates 5-HT systems 
as being necessary for SS behavior, as responding for 2SB 
declined with declining CNS levels of NE and 5-HT but 
responding returned with returning levels of 5-HT rather than 
NE. These investigators also found that increasing brain 
levels of 5-HT had. differing effects depending on current 
levels. With relatively high levels of 5-HT in the CNS, 
rates of responding were lowered at high current intensity 
levels and increased at lower current intensity levels. The 
research of these investigators argues for a 5-HT system which 
has similar or complementary effects on reinforcement 
processes rather than strictly opposite effects.
The present study found that 5-HT release was inhibited 
during the ESB-1 period at the lower current Intensity but 
was very substantially released during ESB-2 in the H group. 
This result is difficult to explain by any simple relation­
ship between 5-HT systems and reinforcement processes. It 
is not consistent with the position that 5-HT mechanisms 
act in opposition to NE mechanisms, but is consistent with 
the position that the two systems work in concert when
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exerting their effects on reinforcement processes. One 
theoretical possibility is that 5“HT mechanisms are not 
operational until current intensities are considerably 
above threshold levels for rewarding effects, and may act 
more in an auxiliary capacity to NE systems rather than as 
direct mediators of reinforcement processes.
A study just reported by Antelman, Lippa, and 
Fisher (1971) utilizing 6-hydroxydopamine which irreversi­
bly destroys noradrenergic end terminals, found first a 
suppression of SS responding corresponding to a depletion 
of brain NE, but with additional testing he found a return 
of SS even though levels of NE never returned. Obviously 
some other compound or system must be substituting for NE.
It could very well be a 5"HT system.
The differential effects on responding produced by 
current intensity changes in the Stark, Boyd, and Fuller 
(1964) study as well as the reversal of direction from 
inhibition to potentiation of release of 5“HT with 
increasing current levels found in this study are consistent 
with the hypothesis that as current intensity is raised a 
serotonergic inhibitory system is invoked; i.e., a homeo­
static steady-state mechanism for response control. The 
release of 5“HT produced by the higher current intensities 
in this study might reflect the activation of that system. 
Then, the decreased responding found in the Stark, Boyd, and 
Fuller (1964) study at higher current intensities with
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higher brain levels of 5-HT would be the behavioral result 
of that system's activation.
The effects produced by higher current intensities 
could of course also be due to the spread of current into 
adjacent neural areas not as directly related to rein­
forcing effects.
Theoretical Speculations on Neural 
Mechanisms in Reinforcement 
At the molecular and functional neurophyslological 
levels, how do biogenic amine brain systems coincide with 
behavioral constructs? Presumably the neurohumors released 
activate certain neural circuits within the limbic area of 
the brain. The question then becomes one of what circuits 
are activated. It is proposed that both NE and 5-HT are 
necessary for the phenomenon of SS, perhaps in a slightly 
different but complementary manner.
Assuming that the NE and 5-HT systems mediate 
reinforcement processes it would be helpful to be able to 
delineate the precise manner in which each system functions 
with respect to reinforcement mechanisms. The neural systems 
may be either completely separate systems or they may be 
overlapping systems both anatomically and functionally.
Evidence cited by Routtenberg (I968) implies that 
there may be two functionally distinct systems which 
mediate reinforcement. There are sites in the septal area 
which when stimulated will support SS, Stimulation to
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these sites also lowers heart rate and inhibits behavioral 
responding for an ongoing task. On the other hand, stimula­
tion sites in the hypothalamus which produce raise heart 
rate and potentiate behavioral responding for ongoing 
behaviors. It is possible that each separate system is 
mediated by a different neural transmitter; i.e., NE and 5-HT, 
Research by Deutsch (1964) directly Implies that 
there are two anatomically distinct neural systems respon­
sible for SS, one system with shorter refractory periods of 
0.5 to 0.6 msec, which is responsible for reinforcement 
effects and another system with longer reftactory periods of
0.8 to 1.1 msec, which is responsible for drive aspects of 
SS. Again it is theoretically possible that a different 
transmitter is involved in each of these separate but 
complementary neural systems. Again the transmitter 
substrate could be NE and 5-HT respectively.
Theoretical Noradrenergic Mechanisms 
NE has historically been associated with activation 
and indeed the 88 phenomena reviewed above seem congruent 
with Hess* concept of an ergotropic substance. Thus, perhaps 
in limbic regions of the brain the organism is incited to 
action via the effects of an adrenergic system. The 
readiness to respond and the maintenance of excitement 
could be under the control of NE circuits. The species 
specific behaviors described by Glickman and Schiff (196?)
1.e., the activation of the consummatory and approach
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behaviors, which are reinforcing, might be initiated by 
NE mechanisms.
Theoretical Serotonergic Mechanisms 
If one considers behaviors in which 5-HT has been 
found to have an effect (Page,1968), many of them involve 
an affective or sensitizing component. Often 5-HT mechanism 
effects depend on the conditions of the biological substrate 
prior to 5-HT's application or release. Perhaps serotonin 
mechanisms function in different ways, depending on the 
current state of the neural system. This might account for 
the sometimes contradictory results for various behaviors 
obtained in different investigations. If 5-HT acts as a 
sensitizing agent it might be expected to heighten pleasure 
in some states of the neural system, and pain in others. 
Thus, one might speculate that 5-HT may be the neurohumor 
which is responsible to a large extent for the affective 
components of reinforcement, the pleasure or pain associated 
with a relnforcer.
Theoretical Interaction of 5-HT 
and NE Mechanisms 
The notion that response readiness aspects of SS 
are mediated by noradrenergic mechanisms and that affective, 
pleasure, or satisfying aspects of SS are in part mediated 
by 5-HT mechanisms does not imply mutually exclusive 
functions for the two monoamines. Indeed based on their
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similar molecular structures, similarity of manufacture and 
degradation, and some similarities at the neurophysiological 
level, they are probably both inextricably involved in any 
behavior in which either is implicated. Thus, at some 
functional level the indoleamine, 5”HT may be able to 
substitute for the catecholamine, NE (e.g., when it is 
depleted as in the Stark, Boyd, and Fuller (1964) and 
Antelman, Lippa, and Fisher (1971) studies) and vice versa.
Perhaps some of Gerbrandt’s (1965) concepts are 
relevant to effects NE and 5-HT may have. He proposes that 
there are responses which are highly stabilized and 
represent the normal mode of action of the animal. (Perhaps 
these may be compared to those species-specific behavior 
patterns postulated by Glickman and Schiff.) During the 
learning process the animal has many competing responses 
which must be controlled. Thus, the Papez circut functions 
to control competing behavior during stabilization. He 
further proposes that the nonspecific projection system 
functions in the release of stabilized behaviors. For 
Gerbrant, a reinforcing stimulus serves to activate limbic 
and midbrain circuts which control or inhibit prepotent 
competing responses.
Within his system the prepotent normal responses 
might be released by NE systems. During reinforcement
5-HT systems come more into use and the 5-HT systems act to 
control or inhibit competing responses. Serotonergic
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mechanism effects might be likened to the effects of 
surround inhibition. Those neural systems which have some 
bias to be Inhibited would be even more inhibited while those 
systems which tend to be activated would be even more 
activated to a certain level beyond which 5-HT mechanisms 
may act to restore equilibrium.
If the above proposed functions of 5-HT and NE 
mechanisms are correct, one is then faced with finding a 
molecular and neurophysiological model whereby 5-HT and KE 
systems could function in this manner.
The molecular structures of NE and 5-HT are very 
similar. If there are sites on the postsynaptic membrane 
which have an affinity for 5-HT on the basis of certain 
structural characteristics, they are likely to have a 
similar though somewhat modified affinity for NE. It might 
even be possible that both neurohumors act on the same 
postsynaptic or presynaptic receptor sites, but in a slightly 
different manner. Indeed there is some evidence to suggest 
that some of the effects of the application of 5-HT on SS 
behavior is due to serotonin's action on the receptor sites 
of NE (Poschel & Ninteman, I968).
One manner in which these two biogenic amines could 
function and be compatible with the above speculations is that 
NE may have a greater affinity for the postsynaptic sites. 
Thus, when 5-HT and NE are released in essentially equal 
quantities, the primary effects produced on the postsynaptic
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sites are those produced by NE by virtue of it being 
preferentially bound to these sites. If however, 5-HT has 
a more potent action on the postsynaptic site than does 
NE, and 5“HT is released in greater quantity than NE, some of 
the 5-HT will become bound with the postsynpatic sites and 
produce its stronger effect (a heightened excitation or 
inhibition, as the case may be) on the postsynaptic membrane. 
Thus, two aspects of these neurohumors might account for 
their varied actions ; the molecular affinity of the 
postsynaptic sites for each of the substances, and the potency 
of action for inhibition or excitation of each substance.
This is only a very general mechanism of action, 
and many of its aspects could vary such as, in neural 
inhibitory mechanisms NE might be the more potent humor 
whereas in neural excitatory mechanisms 5-HT might be the 
more potent humor. It does offer a new manner of examining 
the effects of drugs and neurohumors which have been consid­
ered merely occupying two opposite sides of the coin. The 
implication of such a functioning mechanism would be that 
behavioral and neural effects of KE and 5-HT systems must be 
examined more in concert and under conditions which do not 
substantially alter CNS amine levels than has previously been 
the case.
Further Research Suggestions 
Further research involving the push-pull technique 
should probably center on examining other brain areas than the
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amygdaloid region. In addition a wider variety of current 
levels, and treatment orders might provide useful information 
on the relative importance of NE and 5-HT mechanisms. It 
would also be helpful to examine the release of the biogenic 
amines during ongoing behavioral responding for ESB.
More research with other control compounds such as 
d-norepinephrlne would also further delineate the specificity 
of release of the biogenic amines.
The use of precursor compounds for both NE and 5-HT 
in the ventricular injections would be helpful in assuring 
that the labeled stores are indeed those of the newly 
manufactured NE and 5-HT which are the functionally sig­
nificant fraction. Additionally, analysis of the perfusate 
for the amount and character of the metabolites would 
further clarify the functional relationship of NE and 5-HT 
systems to reinforcement.
The push-pull cannula method lends itself to the 
investigation of the release of other compounds believed to 
affect the 5-HT and NE systems, and might more precisely 
delineate the effects of compounds altering brain levels 
of these amines.
Other research which would be especially helpful 
in delineating the relationship of the two amines would 
employ double-pulse stimulation designed to differentially 
affect the two systems Deutsch (1964) describes and determine 
the relative amounts of NE and 5-HT released under each
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condition.
Additional research might also employ drugs which 
are known to affect SS behavior and also affect biogenic 
amine levels. The drug’s effects on SS would be examined,
3 ts effect on the release of the biogenic amines would be 
examiné using the push-pull cannula technique, and finally 
its effects on the release of the biogenic amines during 
ongoing bar pressing for ESB would be examined using the 
push-pull cannula technique. This paradigm would allow a 
more complete evaluation of NE and 5-HT mechanisms involved 
in reinforcement under conditions of altered brain amine 
levels which have been employed in psychopharmacological 
studies.
CHAPTER V 
SUMMARY
Previous psychopharmacological and biochemical 
research has strongly implicated norepinephrine mechanisms 
in reinforcement behavior. There is also some evidence 
to indicate that serotonergic mechanisms are importantly 
involved. Using a push-pull cannula technique Stein and 
Wise (1969) found that during rewarding electrical stim­
ulation of the brain the biogenic amine NE was released 
from both the lateral hypothalamus and the amygdala.
The purpose of this present research was to 
determine the degree of specificity of release obtained 
using the push-pull technique. Specifically the questions 
addressed were; 1) Is the biogenic amine, serotonin, also 
released during rewarding electrical stimulation of the 
brain? 2) Is a control compound, urea, released during 
rewarding ESB? 3) Will auditory and visual stimulation 
which are presumably neutral in value also elicit release 
of these biogenic amines? 4) Will these biogenic amines be 
released during ESB which is not rewarding?
First, rats were stereotaxically implanted with 
electrodes in the posterior median forebrain bundle, injecter
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cannulae into the lateral ventricle, and push-pull cannulae 
in the amygdala. The electrode sites were then evaluated as 
to whether they were rewarding or non-rewarding using 
operant techniques.
Trace amounts of either C^^5-HT, h35-HT, or
C^^urea were injected into the lateral ventricle. After a 
period of about forty-five minutes the amygdala was perfused 
for a period of five to seven hours. During the perfusion 
there were three treatment periods during which the animals 
received stimulation alternating with control periods of 
no stimulation. During the first two stimulation treatment 
periods the animals were presented with electrical stimulation 
of the brain at the rate of one train of lOOcps stimulation 
per second. The current was raised during the second 
stimulation period. During the third stimulation treatment 
period the animals were presented with auditory and visual 
stimulation at the same rate they received the electrical 
stimulation of the brain.
During the perfusion, samples of the perfusate were 
collected every fifteen minutes and counted in a liquid 
scintillation counter to determine the amount of radioactivity 
present in each sample. The amount of radioactivity present 
during stimulation periods relative to non-stimulation 
control periods was taken as an index of release or non-re 
lease of the compound.
There was a potentiation of release of NE and 5“NT
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but not urea, during rewarding electrical stimulation of the 
brain, and an inhibition of release of NE and 5-HT, but not 
urea, during non-rewarding electrical stimulation of the 
brain. There was no potentiation or inhibition of release 
of these amines during auditory and visual stimulation.
During rewarding electrical stimulation of the brain at 
current Intensities near threshold levels for rewarding 
effects there was an inhibition of release of 5-HT but no
\
potentiation or inhibition of release of NE or urea. '
Both NE and 5-HT mechanisms appear to be involved in 
reinforcement processes since the potentiation of release 
displayed both stimulation specificity for higher current 
intensity electrical stimulation of the brain and chemical 
specificity for the biogenic amines NE and 5-HT.
It is theoretically possible and even probable that 
there are separate neural systems mediating different 
aspects of the reinforcement processes. Each system could be 
mediated by a different neural transmitter (i.e., NE and 5-HT). 
These systems may act in opposition. However, evidence from 
this study in conjunction with other evidence cited in the 
literature is congruent with the proposition that the two 
systems may act is a similar or complementary manner on 
reinforcement processes rather than in an antagonistic 
manner.
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APPENDIX
ABBREVIATIONS
AVS auditory and visual stimulation
B background control period
BroniLSD bromolysergic acid diethylamide
C non^stimulation control
mean of standard scores from the control period 
prior to a stimulation period
C2 mean of standard scores from the control period
after a stimulation period
CNS central nervous system
CPM counts per minute
Dy residual change or difference score (S - E)
DOPA dihydrozyphenylalanine
E expected score
ESE electrical stimulation of the brain
ESB-1 treatment period during which lower current
intensity ESB was given
ESB-2 treatment period during which higher current
intensity Ê8B was given
5-HIAA 5“hydroxy-indole acetic acid
5“HT serotonin ( 5-hydroxytrjrptamine )
5-HTP 5-hydroxytryptophan
5-HTS group injected only with h35-HT (single labeled)
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JB-516 phenyli s opropylhydraz ine
LSD lysergic acid diethylamide
M O  monoamine oxidase
MFB median forebrain bundle
KE norepinephrine
NES group injected only with H^NE (single labeled)
NR non-rewarding
NE + 5-HT group injected with H^NE and C^^5"HT (dual labeled) 
PCPA para-chlorophenylalanine
R rewarding
S mean of standard scores during a stimulation
period
88 self-stimulation
U urea
US group injected with C^^urea
